This year’s EIT Health Summit will explore how we can build a framework for transformation with world-class experts taking to the stage to share expertise, inspiring talks, interactive Q&As, workshops, and deep dive sessions on the most critical topics of European healthcare.

The programme also includes the EIT Health Catapult Final and Award Ceremony where exciting and promising medtech, biotech and digital health start-ups will be selected by a panel of globally renowned healthcare experts and investors.

The live sessions will cover some of the most topical and meaningful issues on the healthcare innovation agenda today, as follows:





Welcome coffee and registration
08:00  to  09:00
Official opening to the EIT Health Summit
09:00  to  09:30

Anders Gustafsson. Vice President. Karolinska Institutet.
Annika Tibell. Director of Research, Development, Education, and Innovation. Karolinska University Hospital.
Annika Szabo Portela. Interim Managing Director. EIT Health Scandinavia.
Lisa Shaw-Marotto. Supervisory Board Chairwoman. EIT Health.
Jean-Marc Bourez. Interim CEO, and France Managing Director. EIT Health.
Welcome Keynote - While the focus for the past 7 years has been on digitisation, the next 7 will be on the retail-isation of healthcare
09:30  to  10:00

Lucien Engelen. CEO, Transform.Health.
Plenary Session - Next-generation health and human-centered innovation
10:00  to  11:00

Healthcare is experiencing unprecedented advances in life sciences and cutting-edge technologies, accelerated even further by the COVID-19 pandemic. To fully leverage the potential of innovation, as well as knowledge and data, a new approach to citizen-oriented health is needed. We must finally make the shift to personalised prevention, focussing on behavioural change and consumer empowerment, strengthening digital infrastructure, investing in the healthcare workforce, fostering data exchange and international cooperation. This is not just a healthcare revolution but a cultural one.

This session will take you on the journey through the cultural transformation in healthcare driven by technological innovation and scientific advances. You will understand how COVID has catalysed digital and hybrid approaches, which are likely to shape the way organisations deliver and citizens manage their own healthcare in the future.

Session Lead: Claudia Pagliari, Director of Global eHealth, University of Edinburgh.

Claudia Pagliari. Director of Global eHealth, University of Edinburgh.
Bogi Eliasen. Director of Health at the Copenhagen Institute For Futures Studies.
Valentina Strammiello. Head of Programmes at European Patients' Forum. European Patients’ Forum.
Mariona Borrell. International Federation of Medical Students’ Association. President.
Coffee Break
11:00  to  11:30
Plenary Session - Rethinking health governance and policy
11:30  to  12:30

The COVID-19 pandemic demonstrated that agile health policies, and trust in health authorities from civil society, are necessary for the wealth and health of individuals. In 2022, we will see the impact of proactive health governance implemented during the early waves of the pandemic, but also what is still to come. While early outcomes of recovery and resilience plans give some guidance for decision-makers, initiatives such as EU4Health, a new mandate for EMA and ECDC, HERA, EHDS, EU pharmaceutical strategy and implementation of MDR are changing health ecosystems in EU Member States and across Europe. Is it enough to help us learn and recover from crisis, be prepared for the next and transform challenges into opportunities?

Join us to discuss the components of sustainable health policy and best practices that have proven their value in recent years and gain insight into where policy will go next within the always evolving ‘new normal’.

Session Lead: Andrzej Ryś, Director responsible for Health Systems, medical products and innovation, Directorate-General for Health and Food Safety (DG SANTE), European Commission.

Peter Arlett (will attend remotely). Head of Data Analytics and Methods Taskforce EMA. European Medicines Agency.
Bettina Ryll. Founder of the Melanoma Patient Network Europe and member of the former EU Cancer Mission Board. Melanoma Patient Network Europe.
Margrietha H. (Greet) Vink. Managing Director, Research Development Office and Research Funding & External Relations. Erasmus Medical Center.
Isabelle Zablit-Schmitz. eHealth Europe & International Director. French Ministry of Health.
Andrzej Ryś. Director Health Systems, Medical Products & Innovation. DG Santé, European Commission.
Lunch Break
12:30  to  13:15
EIT Health Catapult Final: Fast-tracking Europe’s best start-ups
13:15  to  14:15

9 top start-ups of the EIT Health Catapult Programme will pitch their innovations live to a panel of judges and the audience. The three podium finalists in each category (medtech, biotech and digital health) will compete for three prizes. One of the finalists will also win the “Alex Casta Audience Award”. This gives them a unique opportunity to have their logo displayed on the Nasdaq Tower in New York’s Times Square, where it will be seen by millions of people worldwide.

Meet the finalists: 21 start-ups reach EIT Health Catapult Final - EIT Health

Podium finalists:

Biotech category 

Onena Medicines (Spain): makes antibody medicines that force drug resistant cancer stem cells to permanently grow old, rendering them incapable of sustaining and spreading cancer.

SideROS (France): a preclinical stage biotech, developing small molecules targeting iron metabolism to fight cancer resistance, responsible for relapse and metastasis.

SolasCure (UK): makes Aurase®, a hydrogel containing a safe, active, highly specific enzyme, isolated and cloned from medical maggots which promotes faster wound cleaning.

Medtech category 

​Leuko (Spain): develops PointCheck™, a device that can monitor white blood cells non-invasively. White blood cell monitoring is a first-line indicator in cancer chemotherapy and infection detection.

Luminate Medical (Ireland): develops a novel technology to manage off-target drug delivery. Their product, Lily, provides a portable, patient-focused treatment to prevent chemo induced hair loss.

Thinksono (Germany): created the world’s first software for automatic detection of deep vein thrombosis (DVT). DVT is the number one cause of preventable hospital death.

Digital Health category: 

AZmed (France): develops AI-powered solutions improving radiologist’s productivity and diagnostics quality. Their first product Rayvolve detects all types of fractures on X-rays.

Brightlobe (UK): has invented patent-pending technology that can assess and support a child’s brain development using clinically validated mobile games.

Ebenbuild (Germany): develops simulation/AI software to generate data about patients’ lungs, enabling doctors to provide better personalised therapy for Acute Respiratory Distress Syndrome (ARDS).

Kurt Höller. Director of Business Creation. EIT Health.
Coffee Break
14:15  to  14:45

Breakout Sessions (14:45-15:45)

Breakout Sessions (14:45-15:45)
How to anticipate the talent gap in health?
14:45  to  15:45

Room: J3:11

This session deep dives into the talent crunch, the WorkInHealth Foundation programme, the call for corporate donors, and will announce a recent research report about future skills intelligence.

Claire Nassiet. Deputy Managing Director. EIT Health France.
Sophie Maillard. Co-founder & Country Manager France. Minnity.
Manisha Sing. Vice President People Analytics, Digital, Employee Experiences & HR Operations. AstraZeneca.
Breakout Sessions (14:45-15:45)
Spotlight Film: Armed with innovation: the fight to beat the pandemic
14:45  to  15:45

Room: J3:12

Join us for this cinematic experience and watch innovators in action responding to the biggest public health crisis of our time.

EIT Health expedited the initiation of activity to support the fight against COVID-19 in the spring of 2020. New products and services were needed including testing and diagnostics, treatments and vaccines, medical and personal protective equipment, clinical support, and patient monitoring. So we launched 15 projects to find and launch solutions in these areas. Promising European start-ups were also struggling with the economic downturn, so EIT Health launched support to help them weather the storm and continue their vital work. Finally, we launched the ‘making connections’ marketplace which allowed those working in healthcare across the world to connect with others for cooperation opportunities. This COVID-19 special edition tells the story of the actions of the EIT Health community as the pandemic unfolded in an approximately 45-minute film.

Breakout Sessions (14:45-15:45)
Leading from the front: A discussion with our selected leading start-ups (I)
14:45  to  15:45

Room: J3:07

The pandemic has taught us many lessons, not least the need for preventive, predictive and digitised health care. Join  us to hear from a compelling selection of EIT Health supported start-ups and projects implementing solutions such as hybrid care, data-driven approaches to research and development, and preventative measures to keep people healthy and disease-free. Each will present for 7 minutes on their solution and take questions from the audience.

The EIT Health start-ups presenting: 

Breakout Sessions (14:45-15:45)
The untapped power of data in public health
14:45  to  15:45

Room: J3:04

The pandemic has proven unequivocally that public health is intrinsically linked with overall social wellbeing and prosperity. It has also demonstrated the vital role data plays in helping us to prepare, respond and recover from public health threats. That being said, the global approach to data-driven pandemic action was not optimal and there is much to be learned. Join us for this session which will cover how we can use data – and indeed big data - for surveillance purposes to protect society from communicable and non-communicable diseases, how some of the key COVID-19 tracing tools were utilised during the pandemic and how their effectiveness can be improved in the future, and how we can strengthen the resilience of European health systems overall through the utilisation of precise and real-time data.​

Andrea Ammon. Director. European Centre for Disease Prevention and Control.
Nick Schneider. Head of Division 511 on new technologies and data use. German Federal Ministry of Health.
Anna Odone. President. European Public Health Association (EUPHA) Digital health section.

Breakout Sessions (16:00-17:00)

Breakout Sessions (16:00-17:00)
Modern Public-Private Partnership: New ways for faster adoption of healthcare innovations
16:00  to  17:00

Room: J3:07

Established in 2021 by the state-owned Medical Research Agency, in collaboration with the industry giants and EIT Health, the Warsaw Health Innovation Hub (WHIH) is a working model of how countries respond to health challenges thanks to the open innovation formula. The initiative, formed during the pandemic wave, was named the strategic partnership in health in Central Europe and one of the recovery mechanisms to build more resilient healthcare. The Hub connects public and private sectors to co-create innovative medical, technological, and legal solutions to increase the system's efficiency and improve patient care. WHIH develops innovation-friendly conditions allowing for a quick transformation of products, processes, and solutions and easier cooperation between healthcare providers and industry. The business partners build and finance programmes, with an active consultative role of the public side and coordination role of EIT Health, a trusted and experienced partner. Other countries are still looking for optimum models of PPP collaboration. How can we use the power of co-creation to produce mutually beneficial outcomes in healthcare? Can the WHIH model work in other countries as well?

Interactive panel discussion, with practical takeaways and dynamic exchange with the audience, emphasizing practical takeaways and lessons learned.

Balázs Fürjes. Managing Director. EIT Health InnoStars.
Piotr Najbuk. Public and Governmental Affairs Director. AstraZeneca Poland.
Lukas Palaj. Director of Digitalisation and AI Department. Ministry of Health, Slovakia.
Konrád Keresztes. Advisor for Healthcare Industry. Ministry for Innovation and Technology, Hungary.
Breakout Sessions (16:00-17:00)
Biomanufacturing in Europe - Key opportunities
16:00  to  17:00

Room: J3:11

In 2021, EIT Health , together with EIT Manufacturing and  the Council of European BioRegions (CEBR), presented a European Biomanufacturing landscape. The objective has been to explore the conditions conducive to the emergence, development, and industrialisation of disruptive biomanufacturing technologies for advanced therapies or medical technologies in Europe.

Whilst the second wave of the landscape is to be presented in May-June 2022, we will develop throughout the session the main conclusions and most importantly next challenges for the sector. Trying to answer some of the key questions related to

  • the talent gap, and the current experiences and opportunities
  • the innovation struggles and opportunities
  • the business development, and large investments

To illustrate the main findings, we will be accompanied by two representatives of the sector ( investment, and SMEs).

Anaïs Le Corvec. Network manager. Council of European BioRegions.
Iris Öhrn. Investment advisory - Life Science. Business Region Göteborg AB.
Magnus Gustafsson. CBO. Biovian, Finland- Bio-CDMO.
Breakout Sessions (16:00-17:00)
Winning together: a recipe for successful corporate and start-up collaboration
16:00  to  17:00

Room: J3:04

This session will offer both perspectives of a corporate and a start-up who succeeded and walk you through do’s and don’t’s of setting up the right environment for open innovation, where exchange of value is in both directions. You will hear about common pitfalls and learn how to navigate them from those who stay ahead of the curve.

Back in June 2020 McKinsey report on crisis innovation found that over 90% of surveyed executives believed the pandemic would change the way they do business over the next five years, but only 21% felt they were equipped to deliver that change. For many major players partnering with start-ups is the way to disruptive innovation — and for many start-ups, corporates are the key to unlocking new revenue and scaling opportunities. The collaboration of the two unlikely partners will be mutually beneficial when done properly.

Matthias Zach. Programme Lead of Startup Creasphere. Roche.
Anish Shindore. Founder & Managing Partner. GSD Health.
Magda Krakowiak. Head of Open Innovation. EIT Health.
Refreshments & Networking in Aula Medica
17:00  to  17:30
EIT Health Catapult Award Ceremony
17:30  to  18:30
Martin Kern. Director. European Institute of Innovation & Technology.
Kurt Höller. Director of Business Creation. EIT Health.
Cristina Riba. Alex Casta Award. Journalist & TV News Anchor, Televisió de Catalunya.
Ylva Williams. Chief Executive Officer. Stockholm Science City Foundation.
Håkan Sjögren. Managing Director. Nasdaq.
Standing Cocktail Dinner
18:45  to  20:00